UK markets closed

Aclaris Therapeutics, Inc. (ACRS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.3600+0.0500 (+3.82%)
At close: 04:00PM EDT
1.3800 +0.02 (+1.47%)
After hours: 07:56PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts7777
Avg. Estimate-0.29-0.25-0.99-0.82
Low estimate-0.37-0.35-1.35-1.49
High estimate-0.08-0.08-0.32-0.31
Year ago EPS-0.42-0.42-1.27-0.99
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts6666
Avg. Estimate1.37M1.37M5.58M6M
Low estimate570k570k2.26M2.26M
High estimate1.87M1.87M7.48M7.8M
Year ago salesN/A1.9M31.25M5.58M
Sales growth (year/est)N/A-27.90%-82.10%7.50%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.44-0.45-0.48-0.34
Actual EPS-0.42-0.42-0.41-0.02
Difference0.020.030.070.32
Surprise %4.50%6.70%14.60%94.10%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.29-0.25-0.99-0.82
7 days ago-0.29-0.25-0.99-0.82
30 days ago-0.29-0.25-0.99-0.82
60 days ago-0.28-0.25-1.13-1.1
90 days ago-0.31-0.28-1.2-1.21
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesACRSIndustrySector(s)S&P 500
Current qtr.31.00%N/AN/AN/A
Next qtr.40.50%N/AN/AN/A
Current year22.00%N/AN/AN/A
Next year17.20%N/AN/AN/A
Next 5 years (per annum)74.40%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A